The shift: how biotech companies actually pick NYC lab space in 2026
A decade ago, a biotech founder looking for lab space in New York City made calls to two or three real estate brokers, toured whatever they were shown, and signed a lease. The information asymmetry was total. The broker held the inventory; the founder held the checkbook.
That process is breaking down in both directions at once. On one side, purpose-built life sciences platforms like BioLabs, JLabs, and the Deerfield CURE campus have created a new category of “move-in-ready” lab space that didn’t exist ten years ago. On the other side, the pre-search process has migrated to AI. Before a founder calls a broker at CBRE Life Sciences, JLL, or Newmark, they ask ChatGPT, Perplexity, or Gemini: “What are the best life sciences incubators in New York City?” or “Where can I lease biotech lab space in Long Island City?” or “What is the Alexandria Center for Life Science?”
The AI answer shapes expectations, budget assumptions, and the shortlist of buildings the founder will actually visit. CRE brokers who specialize in life sciences — and the landlords and campus operators they represent — are discovering that they now have two discovery problems: getting into the broker’s knowledge and getting into the AI’s knowledge. Only the second is invisible to them.
This article is about both problems. The first section covers the actual inventory: which buildings exist, what they lease, and where they sit in the NYC life sciences ecosystem. The second covers AI visibility: which of those buildings AI actually recommends, why others are invisible, and what it takes to fix that.
Which NYC life-sciences buildings AI actually recommends
Metricus tested structured queries across ChatGPT, Perplexity, Gemini, and Claude in Q1 2026, using buyer-intent prompts that a biotech founder or lab-space tenant would actually use: “Where can I lease biotech lab space in NYC?”, “Life sciences incubator New York City”, “Medical office space Kips Bay”, “Long Island City life sciences lease”, and variations. The results follow a familiar pattern: a small number of well-documented facilities capture nearly all the recommendations; the rest are invisible regardless of their actual quality or availability.
| Rank | Facility | Borough / Neighborhood | Tenant Type | Approx. SF | AI Mention Rate * |
|---|---|---|---|---|---|
| 1 | Alexandria Center for Life Science | Manhattan / Kips Bay | Large pharma, academic spinouts | 728,000 SF (1.3M at completion) | ~85% of relevant responses |
| 2 | CURE at 345 Park Ave South (Deerfield) | Manhattan / Flatiron | Early-to-growth stage biotechs | 300,000+ SF | ~60% of relevant responses |
| 3 | BioLabs@NYU Langone (Innolabs) | Queens / Long Island City | Seed- to early-stage biotech | 46,000 SF (267,000 SF campus) | ~45% of relevant responses |
| 4 | Harlem Biospace / Harlem Biospace @ Mink | Manhattan / West Harlem | Early- to mid-stage biotech | Combined ~25,000 SF | ~25% of relevant responses |
| 5 | BioBAT at Brooklyn Army Terminal | Brooklyn / Sunset Park | Mid-stage biotech, health tech | ~120,000 SF leasable | ~20% of relevant responses |
| — | Avg. other NYC lab building / medical office | Various | Various | Varies | <5% of relevant responses |
* AI mention rates based on structured testing across ChatGPT, Perplexity, Claude, and Gemini using standardized NYC life sciences leasing queries. Full methodology.
The pattern is stark. A handful of facilities — anchored by the Alexandria Center, the Deerfield CURE campus, and the newly relocated BioLabs@NYU Langone — capture the overwhelming majority of AI recommendations. Dozens of other buildings, some of them purpose-built and recently completed, receive essentially no AI mentions at all.
This matters operationally: a biotech company using AI to pre-filter its NYC shortlist will never encounter West End Labs on the Upper West Side, will never see the Brooklyn Navy Yard biotech corridor, and will never find a medical-practice operator’s Kips Bay clinic suites — unless those facilities have done the work to earn AI visibility.
Why most NYC lab and medical office inventory is invisible to AI
AI chatbots generate recommendations from patterns in training data: billions of web pages, news articles, institutional publications, Reddit discussions, and authoritative databases. The buildings that appear most frequently in that corpus — with the most structured, citable content — are the ones AI recommends.
For NYC life sciences real estate specifically, four structural factors push most inventory into invisibility:
1. Thin digital footprint relative to campus size
A 300,000 SF medical-office building in Kips Bay may have a two-page brochure website with no named tenants, no square footage specifics, no pricing language, and no content beyond a phone number. The Alexandria Center, by contrast, has extensive NYCEDC documentation, academic coverage, press releases from every major tenant signing, and repeated mentions in CBRE, JLL, and Cushman & Wakefield life sciences market reports. That documentation gap — not the buildings’ actual quality — determines AI visibility.
2. Broker-mediated discovery suppresses public content
Many NYC life sciences buildings are marketed exclusively through broker relationships, with availability, rent ranges, and floor plans behind NDA or available only upon request. This is deliberate — landlords fear disclosing pricing to competitors. But it also means AI has nothing to cite. A building that cannot be found on LoopNet, CoStar, or any public source essentially does not exist in AI training data.
3. Specialized vocabulary never published in AI-indexable form
The terms biotech tenants actually search — “BSL-2 wet lab lease Manhattan,” “GMP manufacturing space Brooklyn,” “vivarium-capable office Kips Bay,” “tissue culture lab LIC,” “shared autoclave Queens” — are almost never published on building websites in plain HTML. They appear in broker pitch decks and private emails. AI cannot index either.
4. No authoritative third-party coverage for smaller facilities
The Alexandria Center has been covered by the New York Times, Crain’s New York Business, Chemical & Engineering News, and every major CRE publication for over a decade. A smaller incubator that opened in 2022 may have exactly one press release and a LinkedIn post. The Princeton/Georgia Tech GEO research found content with statistical citations and authoritative sourcing is up to 40% more likely to be cited by generative AI (Aggarwal et al., “GEO: Generative Engine Optimization,” 2023). Without authoritative sourcing, smaller facilities are invisible by default.
What AI gets wrong about NYC life-sciences real estate
When AI does recommend a specific NYC life sciences building or campus, the information is frequently incomplete or incorrect. Our Q1 2026 testing surfaced the following recurring error patterns:
Wrong square footage and campus scope
The Alexandria Center is regularly cited as “approximately 1.1 million square feet,” a figure that reflects the planned eventual total (including the North Tower). The current operational campus is 728,000 SF across East and West Towers. The North Tower remains under development. This is not a trivial error: a tenant scoping space expectations against a 1.1M SF campus gets a distorted picture of what is currently available (approximately 33,654 SF in the West Tower as of early 2026).
Stale BioLabs location data
BioLabs@NYU Langone relocated from Varick Street in Manhattan to a new 46,000 SF facility at Innolabs in Long Island City. AI responses from multiple platforms still cite the Varick Street address or describe BioLabs as a Manhattan-only operation — which would cause a Queens-focused founder to miss the option entirely. Innolabs itself (a 267,000 SF campus at 30-02 48th Avenue in LIC, anchored by NYU Langone Health’s 105,000 SF of research programs) is almost entirely absent from AI recommendations despite being one of the most significant new life sciences deliveries in the outer boroughs in recent years.
Harlem Biospace confused as a single location
AI consistently describes Harlem Biospace as a single facility when it now operates two: the original shared wet-lab space in Harlem and the newer Harlem Biospace @ Mink graduation incubator at 1361 Amsterdam Avenue in the Manhattanville Factory District, opened following a $9 million investment by Empire State Development. The @ Mink location serves 12–15 growing firms with up to 210 researchers, a fundamentally different offering from the original shared-bench model. AI conflates them into a generic “biotech incubator in Harlem” with no useful specifics.
BioBAT described with outdated capacity language
BioBAT at Brooklyn Army Terminal received a $50 million investment as part of the city’s expanded LifeSci NYC commitment, significantly expanding its lab capacity. AI responses routinely describe BioBAT in language from its 2014–2016 era — emphasizing its early struggles to attract tenants rather than its 2024–2026 profile as a viable destination for mid-stage companies needing large, affordable floor plates in Brooklyn. Current tenants include Biotia (health tech / microbiome diagnostics) and Calder (vaccine development), neither of which appears in AI-generated tenant lists.
CURE at 345 Park Avenue South misidentified as purely institutional
Several AI platforms describe 345 Park Avenue South as Deerfield Management’s headquarters rather than as a 300,000+ SF innovation campus with move-in-ready wet labs available for lease. The distinction matters: tenants at CURE include ProTara Therapeutics and Helaina, and the building offers a full commercial life sciences ecosystem, not just Deerfield’s own offices. Confusing the two causes tenants seeking external lab space to self-select out before contacting the building.
The compound problem for life sciences CRE: Your building is either invisible in AI (prospective tenants never find it) or described with wrong details (prospective tenants find it and get the wrong picture). Both lose deals. The first is more common — but the second costs more per lost lead because the tenant was already searching for you.
The NYC life-sciences market in 2026: supply, demand, and LifeSci NYC
New York City’s life sciences real estate market entered 2026 in a state of structural tension. Supply is abundant and in some submarkets oversupplied; demand has recovered but is concentrated among a small number of well-funded tenants; and the city’s $1 billion LifeSci NYC initiative continues to inject institutional capital into both construction and programming.
The headline numbers from Crain’s New York Business and broker reports: lab-exclusive availability sits near 27.4%, which is elevated by historical standards but beginning to contract as the new-construction pipeline has thinned. Average asking rents for dedicated lab space in NYC are approximately $96.45 per square foot annually — roughly 38% above the national average of $70/SF cited by CBRE for Q4 2025. The premium reflects the cost of wet-lab buildout in a high-labor, high-real-estate-cost market, not excess demand. Total 2025 leasing increased 138% year-over-year to 377,000 SF, but brokers caution that the improvement was driven by a handful of large transactions, not broad market recovery.
LifeSci NYC — the NYC Economic Development Corporation’s $1 billion initiative, expanded from $500 million in 2021 — remains the dominant institutional force shaping the supply side of the market. Its stated goals: create 40,000 jobs, unlock 10 million square feet of wet- and dry-lab real estate, and generate transformative economic impact over 15 years. As of 2026, the initiative has directly funded or supported the Alexandria Center campus expansion, a $50 million investment in BioBAT, the Harlem Biospace @ Mink opening, the Deerfield CURE partnership, and the upcoming Innovation East project at 455 First Avenue (460,000 SF, anchored by NYU Grossman School of Medicine, with demolition of the existing Public Health Lab building expected in 2026 and construction starting 2027).
Mayor Adams signed legislation in December 2023 to further bolster the city’s life sciences sector, including zoning and permitting reforms that make it easier to convert former office or industrial buildings to lab use. This is directly accelerating conversions in Long Island City, the Brooklyn Navy Yard corridor, and Hudson Square — where JLabs and BioLabs both operate, near Google’s new campus.
The demand side is bifurcated. Large, later-stage companies — Pfizer’s Center for Therapeutic Innovation (Alexandria Center East Tower), Bristol-Myers Squibb (Alexandria Center, NYC HQ), and BlueRock Therapeutics — are anchoring long-term leases in institutional campuses. Early-stage companies are gravitating toward flexible, shared-lab models: BioLabs@NYU Langone at Innolabs, Harlem Biospace, and CURE at 345 Park Avenue South. The middle market — companies that have outgrown incubators but cannot yet commit to a 50,000 SF buildout — remains underserved, which is precisely the gap BioBAT’s large, affordable floor plates in Brooklyn are positioned to fill.
National market context from CBRE’s 2026 US Real Estate Market Outlook: life sciences lab/R&D vacancy dipped to 23% in Q4 2025 nationally as construction hit a seven-year low and absorption turned positive. AI-native biotech firms captured one-sixth of VC funding in 2025, per JLL, suggesting the next tenant cohort will increasingly blend laboratory and computational needs — raising demand for buildings that can accommodate both wet labs and GPU-dense compute infrastructure in the same facility.
The disruptors: 2026 facilities breaking through
Five facilities are changing the composition of the NYC life sciences market in ways that have not yet fully reached AI training data — creating both opportunity for early movers and risk for tenants relying solely on AI-generated shortlists.
| Facility | Neighborhood | Specialization | Notable Recent Tenant / Anchor | AI Visibility Status |
|---|---|---|---|---|
| Innolabs (BioLabs@NYU Langone campus) | Long Island City, Queens | Co-working wet lab, seed- to early-stage biotech | NYU Langone Health (105,000 SF), BioLabs@NYU Langone (46,000 SF) | Emerging; LIC location not yet well indexed |
| West End Labs (125 West End Ave) | Upper West Side, Manhattan | Purpose-built life sciences; office + lab conversion | Graviton Bioscience (30,000 SF) | Low; $15M city grant received but coverage thin |
| Harlem Biospace @ Mink (1361 Amsterdam Ave) | Manhattanville / West Harlem | Graduation incubator; private labs for 12–15 firms | $9M Empire State Development investment; ~210 researchers capacity | Very low; AI conflates with original Harlem Biospace location |
| BioBAT (Brooklyn Army Terminal, Sunset Park) | Sunset Park, Brooklyn | Large-format affordable wet/dry lab; $50M LifeSci NYC expansion | Biotia, Calder (current); International AIDS Vaccine Initiative (anchor) | Low; described with pre-2021 narrative in most AI responses |
| 325 Hudson (Hudson Square lab floors) | Hudson Square, Manhattan | Mixed office / life sciences; near Google HQ + JLabs Hudson Square | Multiple biotech tenants; dedicated life sciences floors | Very low; rarely surfaces in NYC lab space queries |
Each of these facilities represents a genuine, bookable alternative to the Alexandria Center or CURE campus — but none of them surfaces consistently in AI responses to NYC life sciences leasing queries. A CRE broker or campus operator at any of these buildings is effectively invisible in the discovery channel that is increasingly first in line for prospective tenants.
What actually works: the AI-visibility playbook for life-sciences CRE
The good news is that AI visibility for life sciences real estate is tractable. The gap between the Alexandria Center (which dominates AI recommendations) and a newly opened LIC incubator (which AI ignores) is not primarily a gap in quality — it is a gap in documented, structured, publicly available information. Here is what closes that gap:
1. Audit what AI actually says about your building
Before any other step: query ChatGPT, Perplexity, Gemini, and Claude with prompts your prospective tenants use. Document every mention (or absence), every error, every competitor that appears in your place. This is the only way to know whether you have a visibility problem, an accuracy problem, or both. A Metricus report runs this across hundreds of query variations automatically and maps errors to their sources.
2. Publish structured, data-rich content in plain HTML
The most common failure mode for NYC life sciences buildings: all useful information is behind a password or inside a PDF floor plan that AI cannot index. Publish the following in plain, crawlable HTML on your building website:
- Exact square footage available, by floor and configuration
- Lab specification: BSL classification, wet-lab vs. dry-lab, vivarium, autoclave, cold storage, fume hoods
- Named current tenants (with permission) — these are the specific entities AI learns from
- Proximity to hospital systems and academic institutions: Alexandria to NYU Langone is a 500-meter walk; Innolabs is anchored by NYU Langone research programs; BioBAT is affiliated with SUNY Downstate
- Lease terms: minimum duration, base rent range, co-working rates (like Harlem Biospace’s $1,195/desk/month for wet-lab benches)
- Infrastructure specifics: loading dock dimensions, ceiling heights, power capacity, HVAC specifications
3. Earn citations in authoritative life sciences sources
AI weights authoritative mentions heavily. For NYC life sciences real estate, the highest-value citation sources are:
- NYCEDC program pages (Alexandria Center, BioBAT, LifeSci NYC) — NYCEDC mentions carry exceptional weight in AI training data for NYC real estate topics
- CBRE, JLL, and Cushman & Wakefield life sciences market reports — any named mention in a quarterly market report is indexed and cited by AI at high rates
- Crain’s New York Business and The Real Deal tenant signing coverage
- Biotech trade publications: Genetic Engineering & Biotechnology News (GEN), Endpoints News, STAT News
- Academic institution press releases (NYU Langone, Columbia, Cornell Tech, Icahn School of Medicine at Mount Sinai) announcing tenant programs, partnerships, or expansions at your facility
4. Claim and complete your LoopNet, CoStar, and NYCEDC listings
AI aggregates structured data from commercial real estate listing platforms. A LoopNet listing with accurate square footage, named building, specific amenities, and current availability creates a structured data point that AI can cite verbatim. Most NYC life sciences buildings have incomplete or outdated LoopNet listings. Filling them out costs nothing and directly feeds AI training pipelines.
5. Implement structured data markup on your building website
Schema.org markup for LocalBusiness, RealEstateListing, and FAQPage helps AI systems extract and correctly attribute your building’s information. A FAQPage schema with answers to common tenant questions (“Does this building have BSL-2 capacity?” “What is the minimum lease term?” “Which hospital systems are affiliated?”) creates citable Q&A pairs that AI retrieves directly.
6. Run re-audits quarterly
AI training data refreshes on irregular schedules. A building that was invisible in Q1 may begin appearing in Q3 if new authoritative coverage was published in the interim — or vice versa. Quarterly audits catch errors before they persist and confirm when content investments have started returning AI visibility gains.
| Action | Effort | Timeline | Expected Impact |
|---|---|---|---|
| Audit AI responses across major platforms | Low (or use Metricus) | Day 1 | Baseline established; errors mapped |
| Fix factual errors at source (listings, press) | Medium | Week 1–2 | Stops active damage to tenant pipeline |
| Publish plain-HTML specs, sq footage, tenant list | Low–Medium | Week 1–3 | Highest immediate indexability gain |
| Add LocalBusiness + FAQPage schema markup | Medium (dev needed) | Week 2–3 | Improves machine-readability |
| Earn 3rd-party citations (NYCEDC, JLL reports, trade press) | High (ongoing PR) | Week 2–12 | Builds corpus authority; highest long-term impact |
| Re-audit after 90 days | Low | Day 90 | Measure improvement; iterate |
The case for auditing your life-sciences CRE brand’s AI visibility now
NYC life sciences leasing is recovering. The 138% year-over-year increase in 2025 leasing volume tells one story; the 27.4% lab vacancy rate tells another. The market is competitive for tenants — which means buildings and campuses that are easy to discover win disproportionately. A biotech founder who asks AI for their NYC shortlist and never sees your building will not call your leasing broker. They will sign a lease at a building that was visible.
JLL reports AI-native biotech firms already captured one-sixth of VC funding in 2025. These companies were built on the assumption that AI-mediated discovery is the default. Their founders do not distinguish between “the AI says this building exists” and “this building is worth visiting.” That’s the same conflation consumers made with Google in 2005: if you weren’t on the first page, you didn’t exist. The CRE firms and campus operators that established Google presence early captured a structural advantage that compounded for years. The same dynamic is playing out now in AI.
The buildings that are well-documented in public sources today — with accurate square footage, named tenants, lab specifications, and authoritative third-party coverage — will be the ones AI recommends to the next cohort of biotech tenants. The buildings that are invisible today will stay invisible until someone does the work to change it.
The bottom line: If you are a life sciences landlord, campus operator, medical-practice facility manager, or CRE broker with an NYC life sciences portfolio — you need to know what AI says about your buildings. Not next quarter. Before your next prospective tenant asks.
This article gives you the framework. A Metricus report gives you the specific errors, exact source map, and prioritized actions for your life sciences real estate brand — across every major AI platform. One-time purchase from $99. No subscription required.
Related reading
- NYC Class-A Office Leasing and AI Visibility — how AI handles commercial office recommendations in Manhattan and what landlords can do about it.
- NYC Luxury Condo Developments and AI Visibility — the same dynamic in residential new development, with transferable strategies.
- AI Visibility for Real Estate Brokerages — the full framework for any real estate brand operating in an AI-first discovery environment.
- The 5-Step AI Visibility Action Plan — the general framework for turning audit findings into prioritized fixes.
- Fixing AI Hallucinations About Your Brand — deep-dive on correcting factual errors at their source.
- Free AI Visibility Check — run a quick manual check before ordering a full report.
Sources: NYC Economic Development Corporation, Alexandria Center for Life Science program page (edc.nyc); NYCEDC, LifeSci NYC program (lifesci.nyc and edc.nyc); Crain’s New York Business, “NYC biotech leasing improves” and “NYC life science firms slowly move into vacant lab space” (2025–2026); Hoodline / Crain’s, “NYC Biotech Leasing Up in 2025 but Demand Lags” (February 2026); CBRE, US Real Estate Market Outlook 2026 — Life Sciences (cbre.com); Cushman & Wakefield, Life Sciences Update February 2026; JLL, 2025 Life Sciences Real Estate Perspective and Cluster Analysis; Connect CRE / Boston Real Estate Times, BioLabs@NYU Langone Innolabs relocation (2024–2025); Commercial Observer, “NYU BioLabs Adds On at LIC Lab Space” (November 2025); Empire State Development, “Opening of $9 Million Biotech Incubator Harlem Biospace @ Mink” (press release); Governor Hochul, Harlem Biospace @ Mink announcement; BioBAT, LifeSci NYC $50M investment press release (brooklynarmyterminal.com); Gensler / L&K Partners, CURE at 345 Park Ave South documentation; NYCEDC + Deerfield partnership press release; New York YIMBY, Innovation East and SPARC Kips Bay approvals (February 2025, December 2025); 6sqft, “Work to begin on $1.6B life sciences hub in Kips Bay”; Taconic Partners / The Real Deal, West End Labs tenant (2023); Bisnow, “Taconic Invested $2B To Be NYC’s Leading Life Sciences Developer”; Princeton/Georgia Tech GEO study (Aggarwal et al., 2023). AI mention rates based on Metricus internal testing across ChatGPT, Perplexity, Gemini, Claude, and Grok (Q1 2026). Learn more about how we measure AI visibility.